CME & NYSE Target Hyperliquid: Regulators Scrutinize DeFi Derivatives for Manipulation

The old guard is fighting back. CME and NYSE are pushing US regulators to crack down on Hyperliquid, a DeFi derivatives platform raking in $700M annually. This is a direct shot at the decentralized future of trading.

$700 MILLION ANNUAL REVENUE UNDER FIRE!

CME and NYSE are lobbying US regulators to put the screws to Hyperliquid, a DeFi derivatives platform. They're crying foul over market manipulation and sanctions evasion, but this is about turf.

This isn't just some crypto spat; it's the established financial world seeing its lunch eaten by a 24/7, no-KYC, on-chain competitor. Traditional exchanges are feeling the heat.

Hyperliquid is pulling in an insane $65 million per month in fees, totaling $700 million annualized. This cash flow fuels HYPE token buybacks, creating a death spiral for anyone betting against it.

For Binance P2P and Bybit P2P merchants, this means potential volatility. If regulators clamp down, it could disrupt liquidity flows and create new arbitrage opportunities – or wipe out existing ones. Stay sharp.

Expect more regulatory fireworks as DeFi derivatives continue to challenge the legacy financial system. The game is changing, and you need to be ahead of it.